Steven Quay Out of Consideration for Top NIAID Role
· Health · United States
Steven Quay, a biopharmaceutical executive with no background in infectious diseases, is no longer being considered for director of the National Institute of Allergy and Infectious Diseases, STAT reported. Quay is also known as a leading proponent of the lab leak theory of the Covid-19 pandemic's origins. The NIAID directorship is a senior federal post overseeing infectious disease research funding and priorities, and the vacancy has drawn attention amid broader debate over the direction of US public health agencies.
Why it matters:The leadership and direction of a major infectious disease agency affects research funding priorities and pandemic preparedness, with consequences that reach beyond one country's borders.
Key points
- Quay is a biopharma executive with no infectious disease background.
- He is known as a leading lab leak theorist on the Covid-19 origins debate.
- The NIAID director role oversees US infectious disease research priorities.
Sources (original reporting)
More stories from this day
- Pharma Payments to Doctors Tied to Inappropriate Prescribing
- Medicare Advantage Star Ratings for 2027 Released; Humana Biggest Winner
- Florida Dengue Outbreak Becomes Largest in a US State in Decades
- Chai Discovery Signs GSK Deal to Design Biologics with AI
- Microsoft's Nadella Says AI Models Need an 'Emergency Brake'
- AI Debt Issuance Defies Rising Yields as SpaceX and Broadcom Plan Deals